星洲熱股評析
港医院成长催化剂．IHH财测上调
2017-04-04 09:11
IHH医保香港鹰阁医院开门营业，兴业研究看好在市场竞争不大下，有望在一年内达到收支平衡，上调今明两个财年营运盈利2至4%。
（吉隆坡3日讯）IHH医保（IHH，5225，主板贸服组）香港鹰阁医院开门营业，兴业研究看好在市场竞争不大下，有望在一年内达到收支平衡，上调今明两个财年营运盈利2至4%。
兴业研究说，管理层预测香港鹰阁医院（GHK）将在一年内营运盈亏持平，2018与2019年营运盈利各为1亿5900万和4亿1800万令吉，将成为未来盈利增长催化剂。
同时，兴业研究预期IHH医保的成都医院将主要扮演转介功能，将把更复杂棘手的病例或手术转往香港鹰阁。
“但是，考量外汇和拨备等拖累，预测集团2017与2018财政年核心净利将下跌14%与7%。”
整体来看，兴业研究说，基于诸多医院开业初期蒙亏，加上2月公布疲弱业绩后，拖累IHH医保股价落后大市12%，但看好集团将从国内私人需求与区域医疗旅游乘势增长，提高其评级至“买进”，目标价调高至7令吉30仙。
文章来源：
星洲日报‧财经‧2017.04.04http://www.sinchew.com.my/node/1630212/%E6%B8%AF%E5%8C%BB%E9%99%A2%E6%88%90%E9%95%BF%E5%82%AC%E5%8C%96%E5%89%82%EF%BC%8Eihh%E8%B4%A2%E6%B5%8B%E4%B8%8A%E8%B0%83
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
Market Buzz
2024-07-12
IHH2024-07-11
IHH2024-07-11
IHH2024-07-11
IHH2024-07-10
IHH2024-07-10
IHH2024-07-10
IHH2024-07-09
IHH2024-07-09
IHH2024-07-09
IHH2024-07-05
IHH2024-07-05
IHH2024-07-04
IHH2024-07-04
IHH2024-07-03
IHH2024-07-03
IHH2024-07-02
IHH2024-07-02
IHH2024-07-02
IHH2024-07-01
IHHMore articles on 星洲熱股評析
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-07-12 16:40:00
EMA 5
5 Mins
SELL
2024-07-12 16:25:00
ADX
5 Mins
SELL
2024-07-12 15:30:00
TURTLE SYSTEM 20
5 Mins
SELL
2024-07-12 15:30:00
TURTLE SYSTEM 20
10 Mins
SELL
2024-07-12 15:05:00
TURTLE SYSTEM 20
5 Mins
BUY
Apps
Top Articles
1
How to become a resilient trader
2
THE INVESTMENT APPROACH OF CALVIN TAN
RSAWIT (5113) Evidences of a Powerful Turnaround Palm Oil Stock you should not miss!, Calvin Tan
3
4
5
consectetur adipiscing
6
MQ Market Updates
7
Mercury Securities Research
8
Dragon Leong blog
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
